Search Results 1551-1560 of 19447 for Hemoglobin

  1. Mayo Clinic Q and A: What causes low white blood cell count?

    While all white blood cells help your body fight infection, neutrophils are important for fighting certain infections, especially those caused by bacteria.

  2. Aggressive Smoldering Curative Approach Evaluating Novel Therapies and Transplant - Mayo Clinic

    Hemoglobin ≥ 8.0 g/dL;; Total bilirubin ≤ 1.5 x ULN;; ALT and AST ≤ 3 x ULN;. *Cockcroft-Gault Equation: Creatinine clearance for males = (140 - age)(actual ...

  3. TECTONIC CAD IVL IDE Study - Mayo Clinic

    Subject has an untreated pre-procedural hemoglobin \<8 g/dL or intention to refuse blood transfusions if one should become necessary. 13. Subject has a ...

  4. A Study to Evaluate the Addition of Immunotherapy into Adjuvant Therapy for Non-small Cell Lung Cancer - Mayo Clinic

    Hemoglobin ≥ 8 gm/dl;; Calculated (Calc.) creatinine clearance ≥ 45 mL/min;; Total bilirubin ≤ 1.5 x upper limit of normal (ULN);; Aspartate ...

  5. A Study of Ibrutinib as Prophylaxis for Chronic Graft-Versus-Host Disease (GVHD) in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation (allo-HCT) - Mayo Clinic

    Karnofsky Performance Status (PS) ≥ 70. The following laboratory values obtained ≤ 7 days prior to registration: Hemoglobin ≥ 8.0 g/dL (*Untransfused); ...

  6. Lenalidomide in Improving Immune Response to Vaccine Therapy in Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Monoclonal B Cell Lymphocytosis - Mayo Clinic

    Hemoglobin ≥ 11.0 g/dL; Total bilirubin ≤ 1.5 x upper limit of normal (ULN) unless due to Gilbert's disease; if total bilirubin is > 1.5 x ULN, a direct ...

  7. 64Cu-SAR-bisPSMA And 67Cu-SAR-bisPSMA For Identification And Treatment Of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE) - Mayo Clinic

    Hemoglobin ≥9 g/dL (5.59 mmol/L);. Total bilirubin ≤1.5 x the institutional upper limit of normal (ULN). For participants with known Gilbert's Syndrome ≤3 ...

  8. Neurosurgery - Clinical trials

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

  9. Veliparib and Topotecan Hydrochloride in Treating Patients with Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer - Mayo Clinic

    Hemoglobin ≥ 9.0 g/dL; Platelets ≥ 100,000/mcL; Total bilirubin ≤ 1.5x the upper limit of normal (ULN); Serum glutamic pyruvic transaminase (SGPT) (alanine ...

  10. Obinutuzumab With or Without PI3K-delta Inhibitor TGR-1202, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma - Mayo Clinic

    Serum or plasma hemoglobin; Ann Arbor stage Additionally, patients must have beta-2-microglobulin collected at time of registration. Females of childbearing ...